Bart H. Steiner
Impact in
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
- Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment
Papers in
- Genetics 3
- Chronic Lymphocytic Leukemia Research 3
- Virus-based gene therapy research 1
-
- PI3K/AKT/mTOR signaling in cancer 6
- Studies on Chitinases and Chitosanases 1
- Bone Metabolism and Diseases 1
- Co-authors
- Kamal D. Puri (6 shared papers)Adam Kashishian (4 shared papers)Brian Joseph Lannutti (4 shared papers)Sarah A. Meadows (3 shared papers)Amy Jo Johnson (3 shared papers)John C. Byrd (3 shared papers)Neill A. Giese (3 shared papers)Marc Loriaux (1 shared paper)
- Journals
- Blood (3 papers)Journal of Medicinal Chemistry (2 papers)The Journal of Immunology (2 papers)Journal of Biological Chemistry (2 papers)Molecular and Cellular Biology (1 paper)
- Partner nations
- United StatesJapanItaly
In The Last Decade
Bart H. Steiner
13 papers receiving 1.1k citations
Bart H. Steiner's Hit Papers
Peers
Comparison fields: 5 of 67
- Genetics 283
- Pathology and Forensic Medicine 184
- Molecular Biology 414
- Immunology 126
- Rheumatology 45
Countries citing papers authored by Bart H. Steiner
This map shows the geographic impact of Bart H. Steiner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bart H. Steiner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bart H. Steiner more than expected).
Fields of papers citing papers by Bart H. Steiner
This network shows the impact of papers produced by Bart H. Steiner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bart H. Steiner. The network helps show where Bart H. Steiner may publish in the future.
Co-authors
The 25 scholars most cited alongside Bart H. Steiner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | CAL-101, a p110δ selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability Hit paper breakdown → | 2010 | 656 |
| 2 | 2000 | 123 | |
| 3 | 2020 | 82 | |
| 4 | 2000 | 65 | |
| 5 | 2016 | 45 | |
| 6 | 2014 | 44 | |
| 7 | 2016 | 43 | |
| 8 | 2013 | 37 | |
| 9 | 2016 | 30 | |
| 10 | 2016 | 20 | |
| 11 | 1990 | 19 | |
| 12 | 2009 | 7 | |
| 13 | 2008 | 4 |
About Bart H. Steiner
Bart H. Steiner is a scholar working on Genetics, Molecular Biology, Immunology and Allergy, Rheumatology and Immunology, having authored 13 papers that have together received 1.2k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (6 papers), Chronic Lymphocytic Leukemia Research (3 papers), Studies on Chitinases and Chitosanases (1 paper), Systemic Lupus Erythematosus Research (1 paper), Virus-based gene therapy research (1 paper), Bone Metabolism and Diseases (1 paper), T-cell and B-cell Immunology (1 paper) and Chemokine receptors and signaling (1 paper). The work is most often cited by research in Genetics (283 citations), Pathology and Forensic Medicine (184 citations), Molecular Biology (414 citations), Immunology (126 citations) and Rheumatology (45 citations). Bart H. Steiner has collaborated with scholars based in United States, Japan and Italy. Frequent co-authors include Kamal D. Puri, Adam Kashishian, Brian Joseph Lannutti, Sarah A. Meadows, Amy Jo Johnson, John C. Byrd, Neill A. Giese, Marc Loriaux, Sarah E. M. Herman and Roger G. Ulrich. Their work appears in journals such as Blood, Journal of Medicinal Chemistry, The Journal of Immunology, Journal of Biological Chemistry and Molecular and Cellular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.